SPONSORSHIP OPPORTUNITIES ADVANCING CALIFORNIA BIOMEDICAL RESEARCH AND INNOVATION *BRAND RECOGNITION * MARKETING OPPORTUNITIES * NETWORKING * ACCESS*

Transcription

1 ADVANCING CALIFORNIA BIOMEDICAL RESEARCH AND INNOVATION SPONSORSHIP OPPORTUNITIES *BRAND RECOGNITION * MARKETING OPPORTUNITIES * NETWORKING * ACCESS* Mol l y Ingra ha m, Vic e P re si d e n t B u si n e ss D e v e l o p men t I hi. o rg o r ( 8 5 8) w ww.ch i. o rg / s po n s o rs hi p s 1

2 LETTER FROM THE CEO DAVID L. GOLLAHER, PH.D. Dear colleagues and friends, On behalf of CHI and our board of directors, I want to thank you for supporting the activities of CHI. CHI s more than 275 life sciences companies and academic institutions deliver a powerful message about the number of people who work in the biomedical field, our economic impact on the state, and our global leadership in translating basic science into products that save and improve patients lives. In 2013, CHI will embark on its 20th year of advancing biomedical research, investment and innovation through effective advocacy of policies to improve public health and drive California life sciences sector. CHI is well positioned to continue driving the innovation agenda in Sacramento and Washington. In this critical time for the California life sciences industry, we appreciate and rely on your continued financial support and active participation in our organization and events. At our events we strive to deliver high value content and timely analysis of trends affecting our industry to meet the immediate demands of your organizations. Thank you for your continued support of CHI, the voice of the California biomedical community in Sacramento and on Capitol Hill. I look forward to working with you. Sincerely, David L. Gollaher, Ph.D. President & CEO CHI-California Healthcare Institute 1

3 ABOUT CHI CHI is the only statewide organization in California and represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, public and private academic research organizations, along with the legal, accounting, consulting and financial service organizations that support them. CHI s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI s website is Follow us on and on Facebook. Our Value and Mission: The mission of CHI is to research, develop, and advocate policies and actions that promote biomedical science, biotechnology, pharmaceutical and medical device innovation in California. Create a favorable environment for the state s biomedical and healthcare technology community to discover, produce, and deliver products that benefit society. Provide a forum to identify, analyze, and develop positions on public policy issues that affect California s biomedical and healthcare technology interests. Conduct research as a basis for advocating responsible state and federal policies. Communicate to public officials, providers, patients, and the general public the value of the state s healthcare technology community for the health and economic well-being of our nation s citizens and the economic growth of California. Identify and communicate the value of innovation with regard to cost, benefit, and patients quality of life. TABLE OF CONTENTS AUDIENCE DEMOGRAPHICS PROGRAM DESCRIPTIONS SPECIAL PROJECTS CONTRIBUTING TO CHIPAC CHI SCHOLARSHIP PROGRAMS CHI DIAMOND SPONSORSHIP PROGRAM SPONSORSHIP LEVELS AT A GLANCE CHI BOARD OF DIRECTORS CHI MEMBERS SPONSORSHIP COMMITMENT FORM

4 AUDIENCE DEMOGRAPHICS 3

5 PROGRAM DESCRIPTIONS WINTER - ANNUAL CALIFORNIA BIOMEDICAL INDUSTRY REPORT The Annual California Biomedical Industry Report illustrates the important roles biomedical research, development, and manufacturing play in California s economy and ultimately in the nation s health. The report provides an overview of employment trends, wages, the product development pipeline, and opportunities and risks for the industry in California, home to the largest concentration of biomedical companies in the world. CHI, in partnership with BayBio and PwC, publishes the report annually in print and on an interactive website that is regularly updated with industry data, news and accomplishments. The report is launched through a series of events to publicize its key findings to the media, policy makers and the California life sciences community including: a press conference with an invitation-only networking breakfast held in San Francisco during the Annual J.P. Morgan Healthcare Conference, a reception with state elected and appointed officials in Sacramento, and regional program panel discussions held in key biomedical clusters throughout the State. Platinum Sponsor Benefits - $10,000 Recognition of research milestone, product development achievement, patient care advance, or other significant company accomplishment on interactive website for the Annual California Biomedical Industry Report* Opportunity to participate as media spokesperson for launch of Annual California Biomedical Industry Report Opportunity to participate in speaking or other role at regional launch events for Annual California Biomedical Industry Report* Platinum-level preferred seating at press conference with an invitation-only networking breakfast to be held in San Francisco during the Annual J.P. Morgan Healthcare Conference in January Table for eight guests at press briefing and event to be held in San Francisco during the Annual J.P. Morgan Healthcare Conference in January. Photo opportunity with policymakers at launch event in Sacramento Invitation to exclusive sponsor-only reception with policymakers in Sacramento Platinum-level recognition on printed and electronic materials Platinum-level corporate logo positioning on event signage Platinum-level recognition on CHI, BayBio and partnering organization websites Platinum-level recognition during event presentations Non-Profit/Academic Research Institution Sponsor - $3,500 Gold Sponsor Benefits - $5,000 Two complimentary tickets to press conference with an invitation-only networking breakfast to be held in San Francisco, California during the Annual J.P. Morgan Healthcare Conference in January Photo opportunity with policymakers at launch event in Sacramento Invitation to exclusive sponsoronly reception with policymakers in Sacramento Gold-level recognition on printed and electronic materials Gold-level corporate logo positioning on event signage Gold-level recognition on CHI, BayBio and partnering organization websites Gold-level recognition during event presentations Non-Profit/Academic Research Institution-level recognition on printed and electronic materials Non-Profit/Academic Research Institution-level corporate logo positioning on event signage Non-Profit/Academic Research Institution-level recognition on CHI website Non-Profit/Academic Research Institution-level recognition during dinner presentation Non-Profit/Academic Research Institution-level preferred seating at dinner Company recognition in CHI printed material is subject to deadlines determined by CHI. *Subject to CHI, PwC, and BayBio approval 4

6 SPRING - ANNUAL RECEPTION ON CAPITOL HILL (WASHINGTON, D.C.) CHI gathers legislators, their staff and leaders from the lifesciences and academic communities in California for a celebration of California biomedical innovation at our nation s capital. Hundreds of attendees enjoy conversation with public policymakers and California s biotech opinion leaders about the issues that matter most to our industry. At the invitation-only dinner following the reception, we honor legislators who have supported the advancement of biomedical innovation in California. Past awardees have included Fred Upton, Chairman, House Energy & Commerce Committee, Representative Kevin McCarthy, Representative Anna Eshoo, Senator Dianne Feinstein and Representative Mike Thompson. Platinum Sponsor Benefits - $7,500 One seat at honoree table with member of Congress* at private, invitation-only Board of Directors dinner Table for eight guests at the private, invitation-only Board of Directors dinner Photo opportunity and special memento framed photograph with member of Congress* Opportunity for participation in dinner presentation with member of Congress* Platinum-level recognition on commemorative dinner program Platinum-level recognition on printed materials promoting the reception to legislators, legislative staff, life sciences industry executives, patient advocates and health policy community Platinum-level recognition on broadcast s to key audiences listed above Platinum-level recognition on CHI website Platinum-level recognition during the dinner *schedule permitting Gold Sponsor Benefits - $3,000 Two complimentary tickets to private, invitation-only dinner honoring member of Congress Gold-level recognition on printed materials promoting the event to legislators, legislative staff, life sciences, industry executives, patient advocates and health policy community Gold-level recognition on broadcast s to key audiences listed above Gold-level recognition on CHI website Company recognition in CHI printed material is subject to deadlines determined by CHI. 5

7 SUMMER - AN EVENING WITH THOUGHT LEADERS (SOUTHERN CALIFORNIA) CHI s annual summer program An Evening with Thought Leaders brings together hundreds of leaders from California s biomedical industry, academic research community, entrepreneurs, investors, healthcare providers, policy experts and patient advocates. Past speakers have included: Dr. Charles Edwards, former director of the U.S. Food and Drug Administration, past president and CEO of Scripps Clinic and Research Foundation, and former president and CEO of Scripps Institutes of Medicine and Science Brook Byers, well-known venture capitalist Dr. Richard Murphy of the California Institute for Regenerative Medicine and Salk Institute Former Secretary of State and Distinguished Fellow at the Hoover Institution, Stanford University, George P. Shultz Dr. Eric Topol of the West Wireless Health Institute Margaret Anderson, Executive Director, FasterCures Dr. Robert Figlin, Director Division of Hematology/Oncology, Cedars Sinai Dana Goldman, Ph.D., Director, USC Leonard D. Schaeffer Center for Health Policy and Economics Frank McCormick, Ph.D., Director of the Helen Diller Family Comprehensive Cancer Center at UCSF, President of the American Association of Cancer Research Kim Popovits, President & CEO, Genomic Health Platinum Sponsor Benefits - $20,000 Exclusive sponsorship one sponsorship per service sector Eight complimentary admissions to program Table of eight at dinner Opportunity to speak at event* Distribution of giveaway to attendees* Opportunity to serve on Event Steering Committee* Opportunity to display corporate literature and exhibit at event Platinum-level preferred seating at event Platinum-level recognition during program proceedings Platinum-level placement of corporate logo and branding in printed and electronic materials promoting the event Platinum-level recognition on CHI website and partner organization websites Platinum-level recognition on event signage Gold Sponsorship Opportunity - $10,000 Opportunity to serve on Event Steering Committee* Four complimentary admissions to event Opportunity to display corporate literature and exhibit at event Gold-level recognition during program proceedings Gold-level placement of corporate logo and branding in printed and electronic materials promoting the event Gold-level recognition on CHI website and partner organization websites Gold-level recognition on event signage Silver Sponsor Benefits - $5,000 Two complimentary admissions to event Opportunity to display corporate literature and exhibit at event Silver-level recognition during program proceedings Silver-level placement of corporate logo and branding in printed and electronic materials promoting the event Silver-level recognition on CHI website and partner organization websites Silver-level recognition on event signage *Subject to CHI approval Company recognition in CHI printed material is subject to deadlines determined by CHI. 6

8 FALL - DIAGNOSTICS FORUM The diagnostics industry is changing rapidly, fueled by basic scientific advances in genomics and molecular genetics, along with technological innovations in areas like gene sequencing. It is clear that policy, reimbursement and regulation have not kept pace with this fast-moving field. To build a better understanding of the complex regulatory and political environment surrounding diagnostics, and to refine our advocacy agenda, CHI hosts this half-day forum. CHI convenes industry executives, policymakers and regulators, as well as policy experts to discuss topics such as regulation of laboratory-developed tests, regulatory approaches to sequencing, reimbursement of advanced diagnostics, reimbursement, and other vital topics. SPONSORSHIP OPPORTUNITY CHI DIAGNOSTICS WORKING GROUP 23andMe Abbott Laboratories BD CardioDx Celera Cepheid Crescendo Bioscience Genentech Genomic Health Hologic + Gen-Probe Genzyme Illumina Johnson & Johnson Kleiner Perkins Caufield & Byers Novartis Pfizer Roche Diagnostics Wave 80 Biosciences Sponsor Benefits - $3,500 Opportunity to present at forum Opportunity to guide white paper development and distribution strategy Two complimentary passes to forum Recognition on printed and electronic materials promoting the forum Recognition on CHI website Recognition during the forum program and reception Company recognition in CHI printed material is subject to deadlines determined by CHI. 7

9 FALL - CHI ANNUAL MEETING (BAY AREA) CHI s Annual Meeting is focused on the relationship between biomedical innovation and public policy. This event brings together delegates from more than 200 of CHI s member organizations with policymakers to discuss critical issues and opportunities facing the biomedical community. The goal of the forum is to produce a clearer understanding of the biomedical community s work and needs, and how the industry can sustain California s leadership in medical innovation. Exclusive Board of Directors Dinner Sponsor Benefits - $25,000 Six complimentary full access registrations Table of eight at private, invitation-only Board of Directors dinner Opportunity to display corporate literature at forum and at dinner Leveraged exposure in promotional campaign that reaches more than 5,000 California biomedical industry executives Opportunity for senior level management to introduce panel discussion at forum Opportunity for senior level management to address dinner guests Recognition at event Recognition in attendee materials Recognition on CHI website Recognition on printed and electronic materials promoting the event Corporate logo on event signage Platinum Sponsor Benefits - $20,000 Six complimentary full access registrations Opportunity to display corporate literature Leveraged exposure in promotional campaign to reach more than 5,000 California biomedical industry executives Opportunity for senior level management to introduce panel discussion Distribution of giveaway to attendees* Recognition at event Platinum-level recognition in attendee materials Platinum-level recognition on CHI website Platinum-level recognition on printed and electronic materials promoting the event Corporate logo on event signage *subject to CHI approval Gold Sponsor Benefits - $10,000 Four complimentary full access registrations Leveraged exposure in promotional campaign to reach more than 5,000 California biomedical industry executives. Gold-level recognition in attendee materials Gold-level recognition on CHI website Gold-level recognition on printed and electronic materials promoting the event Opportunity to display corporate literature Corporate logo on event signage Company recognition in CHI printed material is subject to deadlines determined by CHI. 8

10 Silver Sponsor Benefits - $5,000 Two complimentary full access registrations Leveraged exposure in promotional campaign to reach more than 5,000 California biomedical industry executives. Silver-level recognition in attendee materials Silver-level recognition on CHI website Silver-level recognition on printed and electronic materials promoting the event Corporate logo on event signage Innovations like those being developed at NuVasive and at other companies throughout California are having a huge impact on the economy and on the improvement of human lives. This event allows us to elevate the importance of keeping biomedical companies and jobs in California. - Keith C. Valentine, President and Chief Operating Officer, NuVasive Coffee and Networking Break Sponsor Benefits - $5,000 Two complimentary registrations Opportunity to display corporate literature Logo prominently displayed throughout the break area Recognition on printed and electronic materials promoting the event Patient & Non-Profit Organization Scholarship Sponsor Benefits - $5,000 Patient & Non-Profit Organization Scholarship-level recognition of sponsor to scholarship recipients Two complimentary full-access registrations Opportunity to display corporate literature Recognition on printed and electronic materials promoting the event Corporate logo on event signage Opportunity to meet with speakers and other VIPs in a more private setting Company recognition in CHI printed material is subject to deadlines determined by CHI. 9

11 ANNUAL END OF SESSION RECEPTION (WASHINGTON,D.C.) To celebrate the end of the legislative session in Washington D.C., CHI brings together legislators, staff and biomedical industry leaders in an informal setting. The event attracts key members of Congress, top-level legislative staff and other government officials. During the event, attendees have the opportunity to meet and talk one-on-one with policymakers and their staff about the importance of biomedical innovation and scientific advancement in California and globally. SPONSORSHIP OPPORTUNITY Sponsor Benefits - $1,500 Recognition on printed materials promoting the event to legislators, legislative staff, life sciences industry executives, patient advocates and health policy community Recognition on broadcast s to key audiences listed above Corporate logo on CHI website Recognition during the reception CHI POLICY ROUNDTABLE SERIES CHI hosts private, informal roundtable discussions with state and federal policymakers that offer important opportunities to engage in high level discussion. Topics include the importance of life sciences research, development and innovation in and around legislators districts, science funding, capital formation, FDA regulation, science and math education, and workforce development. These roundtables are small, open to only 15 CEOs at a time. SPONSORSHIP OPPORTUNITY Underwriting opportunities for CHI s policy roundtable series are customized for each event. Mol l y Ingra ha m, Vic e P re si d e n t B u si n e ss D e v e l o p men t I hi. o rg o r ( 8 5 8) w ww.ch i. o rg / s po n s o rs hi p s 10

12 SPECIAL PROJECTS NATIONAL INSTITUTES OF HEALTH: RETURN ON INVESTMENT CASE STUDIES Sponsorships are available at the Corporate Level ($10,000) and Non-Profit/Academic Research Institution Level ($5,000). NIH is the world s leading sponsor of biomedical research. California s preeminence in the life sciences industry derives, in large part, from universities and private research institutes supported by the NIH. During the past decade the NIH budget, after doubling from , has barely kept up with inflation. And the percentage of investigator-initiated grant proposals approved for funding has steadily declined. There now is a prospect for significant cuts in 2013, owing to sequestration and general pressure to reduce discretionary federal spending. While the immediate effects of NIH cuts would be felt by organizations engaged in basic research, the longer-term impact would hamper companies that provide research tools and, eventually, weigh on the whole biomedical sector as its main source of new inventions declined. Several published economic studies produced data to demonstrate how the NIH drives job creation and economic growth. But CHI believes that, within the current political environment with its emphasis on job creation and U.S. competitiveness, there s an urgent opportunity to illustrate the value of NIH funding, and the return on government investment in basic science, by developing a series of case studies. Our basic concept is to select areas beginning with recombinant DNA and HIV/AIDS in which comparatively modest funding from NIH served as catalysts for tremendous advances, subsequently encouraging private-sector investment and commercial activity, and rapidly bringing major advances in human health. CHI s communication efforts will include a joint release to the media and general public of the reports with NIH, congressional briefings and one on one meetings with legislators and their staffs. Sponsors of the project will have the opportunity to participate in content development and communication and project launch activities. COVERAGE, PAYMENT AND THE VALUE OF BIOMEDICAL INNOVATION Sponsorships are available at the Presenting Level ($25,000) and Supporting Level ($10,000). Reasonable coverage and payment policies beginning with CMS, Medi-Cal and other public sector payers are essential to sustaining U.S. medical innovation. As reimbursement has declined, in some cases the return on investment in R&D for new products has fallen below the cost of capital, making R&D value destroying. In order to advocate for pro-innovation policies in an environment with tight fiscal constraints and high levels of political polarization, CHI is designing a comprehensive program to run through 2013 and beyond. We are presently engaged in discussion with Avelere Health, a Washington-based consulting firm that works with many CHI drug and device companies, about a partnership that would tap into the firm s expertise in data analytics and government payers. As with our FDA project with Boston Consulting Group, we plan to organize a committee of CHI members to guide the work. Sponsors of the project will be invited to serve on the advisory committee. Our approach will include: Developing a data-driven approach for estimating the value of stateof-the-art diagnostic tests and treatments; Navigating the changing currents of comparative effectiveness research, aiming to ensure that it is not used as a tool to limit access to advanced technologies; Keeping close watch on the Independent Payment Advisory Board (IPAB), a panel of 15 presidential appointees charged with making Medicare cuts to achieve budgetary goals; and Monitoring the progress of California s health insurance exchanges and the development of essential benefits to ensure that efforts to reign in health insurance premiums, exchanges do not impose new barriers to innovative technologies. 11

13 CONTRIBUTING TO CHIPAC The California Healthcare Institute State Political Action Committee (CHIPAC) is a bipartisan state political action committee established to solicit voluntary political contributions. The CHIPAC enables companies and individuals to combine their resources to support state-level candidates who demonstrate a dedication to understanding California s biomedical industry, encouraging the industry to flourish in the state, and fostering drug, device and diagnostics innovation. Unlike federal law, corporations are allowed under California law to make political contributions to a state PAC. As of January 1, 2009, the limit is $6,500 per calendar year. What is the purpose of the CHIPAC? The purpose of the CHIPAC is to elevate awareness of the biomedical industry s goals through increased education and participation in the political process in California. The CHIPAC aims to educate, inform and elect candidates to state office who will support and promote California s biomedical industry. The CHIPAC allows the biomedical industry to support candidates who share our values and want to help our industry conduct business in California; develop, commercialize and market new medical products; and maintain a highly skilled workforce. Why contribute to the CHIPAC? The CHIPAC allows you and your company the opportunity to unite with other industry leaders to ensure that Sacramento policy makers hear your views. Elected officials in California have direct influence on how you and your company conduct business in the state and how your products are developed, regulated and marketed in California. By contributing to the CHIPAC, you can help ensure that these key officials understand and appreciate the unique challenges facing medical innovators. Who may contribute to the CHIPAC? Any individual or company that has an interest in maintaining a business, legal and regulatory climate that supports and advances biomedical innovation in California may contribute to the CHIPAC. How does the CHIPAC decide where to direct political contributions? All members of the CHIPAC are involved in decisions on directing political contributions to state-level candidates. In addition, members of the CHIPAC meet with candidates and evaluate the candidates positions on key issues of concern to the biomedical industry. The CHIPAC may also contribute to those already in office who have demonstrated leadership in advancing biomedical innovation and patient access in California. How much may I contribute to the CHIPAC? Participation in the CHIPAC is voluntary and there is no minimum donation; the maximum allowed by any individual or company (and its subsidiaries) is $6,500 per calendar year. A suggested contribution level for personal donations, consistent with average contributions to other PACs, is ½ percent to 1 percent of salary. Annual contributors receive a wide array of benefits based on their contribution level including complimentary event attendance, recognition by the CHIPAC and educational materials. How do I join the CHIPAC? Go to and complete the online CHIPAC participation form with a contribution. United we can support candidates who encourage medical innovation, advance product development, and promote the growth of the life sciences industry in California. Contact Consuelo Hernandez ( or Hernandez@chi.org) or Molly Ingraham ( or ingraham@chi.org) to join and contribute. 12

14 CHI SCHOLARSHIP OPPORTUNITIES CHI offers opportunities for students, patients and speakers to attend CHI events and meet and network with biomedical leaders and policymakers. Students can be enrolled in a two- or four-year accredited university studying a science or business major in the lifesciences or biomedical industry. Each donation ensures that more individuals can receive support to continue fostering biomedical innovation in California. Scholarship Benefits Enhance your visibility as an industry leader who fosters education and career advancement. Ensure a qualified workforce and develop the lifesciences industry leaders of tomorrow. Increase the opportunity for more qualified students to receive scholarships through CHI. Scholarship Options Platinum Scholarship Funds - $50,000+ Contributors establish a named endowment scholarship fund by committing to donate a minimum of $50,000 (in one to four years). The funds generated are used to distribute scholarships starting at $2,000 to qualified applicants. Gold Scholarship Funds - $25,000+ For the opportunity to have a scholarship named and represented by your company or an individual s name, this is the option for you. The Gold Scholarship Fund is an active expendable fund that allows contributors to donate $25,000 or more in a given year. The contribution is used to distribute scholarships starting at $2,000 to qualified applicants. General Scholarship Program Scholarship donors will be recognized for any size donation. This fund supports highly qualified recipients from our general pool of applicants. Scholarship Fund Recognition: Scholarships awarded in the name designated by the donor The opportunity to invite scholarship recipients to CHI events Recognition on CHI website Recognition at CHI events Invitation to attend CHI events CHI DIAMOND SPONSORSHIP PROGRAM As an industry, we face serious challenges in the years ahead due to the consequences of the recent economic turmoil. We need to sustain a strong, consistent voice in the ongoing debate over medical innovation in order to foster a favorable policy and economic environment. The CHI Diamond Sponsorship Program enables your company to donate a lump sum for CHI to use to support our public policy programs and outreach to the California congressional delegation, key congressional committees, federal and state agencies, state legislators and legislative staff. These grants will significantly benefit CHI s public policy research and advocacy at the federal and state levels in the future, and increase CHI s impact in both areas. As a donor, you will receive regular reports on how the funding is applied, the progress we are making, and the results we achieve. As an organization, we are inspired by your confidence in CHI to educate policymakers about the key issues facing life sciences innovators. CHI will work to create a customized package for you. Contact Molly Ingraham, vice-presidentbusiness development to learn more (Ingraham@chi.org or ). 13

15 SPONSORSHIP LEVELS AT A GLANCE Winter - Annual California Biomedical Industry Report (Sacramento) Benefits Additional Benefits Sponsorship Opportunities Exclusive reception with policy makers in Sacramento Recognition on print/ electronic materials Speaking opportunites at project-related events 1 Photo Opportunity with policymakers Platinum $10,000 Preferred seating at project-related events; Table for eight guests at press briefing and event to be held in San Francisco during the Annual J.P. Morgan Healthcare Conference. Gold $5,000 Two complimentary tickets to press conference and invitation-only networking breakfast at J.P. Morgan Healthcare Conference Non-Profit/Academic Research Institution $3,500 Two complimentary tickets to press conference and invitation-only networking breakfast at J.P. Morgan Healthcare Conference 1 Subject to CHI, PwC, and BayBio approval Spring - Annual Reception on Capitol Hill (Washington, D.C.) Benefits Additional Benefits Sponsorship Opportunities Complimentary Registrations Recognition on print/ electronic materials Recognition during event Recognition on CHI website Platinum $7,500 8 Seat at honoree table; Photo opportunity with honoree 2 Gold $3, Schedule permitting Summer - An Evening With Thought Leaders (Southern California) Benefits Additional Benefits Sponsorship Opportunities Complimentary Registrations Recognition on print/ electronic materials Recognition during event Recognition on CHI website Literature display Platinum $20,000 8 Exclusive sponsorship; Opportunity to speak*; Table of eight at dinner; Distribution of giveaway to attendees*; Opportunity to serve on Event Steering Committee*; Preferred seating Gold $10,000 4 Opportunity to serve on Event Steering Committee* Silver $5,000 2 * Subject to CHI approval 14

16 SPONSORSHIP LEVELS AT A GLANCE Fall - Annual Diagnostics Forum Benefits Additional Benefits Sponsorship Opportunity Complimentary Registrations Recognition on print/ electronic materials Recognition during event Recognition on CHI website Literature display $3,500 2 Opportunity to present; Opportunity to guide white paper development Fall - CHI Annual Meeting - Bay Area Benefits Additional Benefits Sponsorship Opportunities Complimentary Registrations Recognition on print/ electronic materials Recognition during event Recognition on CHI website Literature display Board Dinner $25,000 6 Table of eight at dinner; Opportunity to speak Platinum $20,000 6 Opportunity to speak; Distribution of giveaway Gold $10,000 4 Silver $5,000 2 Coffee and Networking Break $5,000 2 Patient and Non-Profit Organization Scholarship $5,000 2 End of Session Reception (Washington, D.C.) Sponsorship Opportunity Recognition on printed/ electronic materials Benefits Recognition on CHI website Additional Benefits $1,500 Targeted campaign to congressional offices 15

17 CHI BOARD OF DIRECTORS Carl W. Hull (Chairman) David E. I. Pyott (Chairman-Elect) David L. Gollaher, Ph.D. (President & CEO) David W. Beier Mark Carlson, M.D. Michael V. Drake, M.D. Peter C. Farrell, Ph.D.,DSc, AM Paul Hastings Peter Barton Hutt Vera Janushkowsky Steve E. Krognes Sef P. Kurstjens, M.D., Ph.D Tracy T. Lefteroff John C. Martin, Ph.D. Daniel McIntyre Dana G. Mead, Jr. David Meeker, M.D. Peter G. Milner, M.D., FACC Michael A. Mussallem Maulik Navanaty Christian W. Nolet John C. Reed, M.D., Ph.D. William E. Rhodes John D. Stobo, M.D. Katie M. Szyman Eric J. Topol, M.D. Keith C. Valentine David J. Wilson, Ph.D. Rick E. Winningham Hologic + Gen-Probe Allergan CHI-California Healthcare Institute Amgen St. Jude Medical, Inc. U.C. Irvine ResMed OncoMed Pharmaceuticals Covington & Burling Pfizer Genentech Agensys, Inc. PricewaterhouseCoopers Gilead Sciences Biogen Idec Kleiner Perkins Caufield & Byers Genzyme Optivia Biotechnology Edwards Lifesciences Boston Scientific - Neuromodulation Ernst & Young Sanford-Burnham Medical Research Institute BD Biosciences University of California Medtronic Diabetes Scripps Translational Science Institute, Scripps Health & West Wireless Health Institute NuVasive, Inc. Mentor Worldwide Theravance 16

18 CHI MEMBERS 23andMe Abbott Diabetes Abbott Diagnostics Abbott Hematology Abbott Laboratories Abbott Medical Optics Abbott Vascular Accuray Achaogen Advanced Cleanroom Microclean (ACM) AeroGen Affymax Agensys Alexandria Real Estate Equities Align Technology ALine, Inc Alios BioPharma Allergan Alphatec Spine ALZA Corporation Amgen Amira Pharmaceuticals Amylin Pharmaceuticals Andrew Technologies Aptiv Solutions Aradigm Aragon Pharmaceuticals Arena Pharmaceuticals Armetheon ASP Johnson & Johnson Astellas Pharma US Avalon Ventures Avid Biotics BabyCenter Baxano Bavarian Nordic BD BD Biosciences BD Diagnostics - GeneOhm Beckman Coulter Beckman Laser Institute Berkeley HeartLab Biogen Idec BioMarin Pharmaceutical Biosense Webster Bioniz BiPar Sciences BN Immunotherapeutics Boehringer Ingelheim Boston Consulting Group Boston Scientific Boston Scientific Cryovascular Systems Boston Scientific Electrophysiology Boston Scientific EPI Technology Center Boston Scientific IVT Technology Center Boston Scientific Neuromodulation Boston Scientific Smart Therapeutics Buck Institute for Age Research Cabochon Aesthetics Caltag Laboratories CardioDx Cedars-Sinai Health System Celera Diagnostics Cellegy Pharmaceuticals Centocor Cepheid Cerexa Chapman University City of Hope CODAN U.S. Corporation Conceptus Cooley LLP Cougar Biotechnology Covington & Burling LLP Crescendo Bioscience Cubist Pharmaceuticals Cytokinetics CytRx DePuy DexCom Duane Morris DURECT Edwards Lifesciences Elcelyx Therapeutics Elevation Pharmaceuticals Ernst & Young Exelixis ExploraMed Fabiani & Company FIBERLite Centrifuge Inc. Forest Laboratories Fish & Richardson Genia Genentech Genomic Health Genomics Institute of the Novartis Research Foundation Genoptix Genzyme Corporation Genzyme Diagnostics Genzyme Genetics Gilead Sciences GlaxoSmithKline Ground Zero Pharmaceuticals Histogen Hoffman-La Roche Ltd Hogan Lovells Hologic + Gen-Probe IDA Ireland IDM Pharma, Inc. Illumina Impedimed Interventional Spine Intuitive Surgical irhythm Irvine Scientific Isis Pharmaceuticals ISTA Pharmaceuticals Iverson Genetic Diagnostics J&J Pharmaceutical Research & Development Johnson & Johnson K-Tube Corporation Kleiner Perkins Caufield & Byers LLP KPMG LLP La Jolla Institute for Allergy and Immunology Lazard LTD Leerink Swann 17

19 CHI MEMBERS LifeScan LoneStar Heart McKesson MedImmune MedImmune Vaccines Medtronic Medtronic Cardiovascular (Santa Rosa/Santa Ana) Medtronic Spinal & Biologics (Sunnyvale) Medtronic Diabetes (Northridge) Medtronic Surgical Technologies (Goleta) Mentor Corporation Merck & Co Merrill DataSite Metabolex Microgenics MyMedicalRecords Myoscience NEKTAR Therapeutics NeuroPace Neutrogena Nitinol Devices & Components Nodality Novo Nordisk NuVasive Okapi Venture Capital Oligasis Omniox OncoMed Pharmaceuticals Onyx Pharmaceuticals Ophthonix OptiMedica Optimer Pharmaceuticals Optivia Biotechnology Orexigen Therapeutics Organovo Ortho Dermatologics Pfizer PhotoThera Poniard Pharmaceuticals Portola Pharmaceuticals PricewaterhouseCoopers LLP Proteus Biomedical Quidel Radiant Research Regulus Therapeutics Revance Therapeutics ResMed Rigel Pharmaceuticals Roche Roche Molecular Diagnostics Rox Medical Safety Syringes Sanford-Burnham Medical Research Institute Sangamo BioSciences Sangart Santarus Scios SI-Bone Sidley Austin Siemens Healthcare Sientra SinuSys Spectrum Pharmaceuticals Sonitus SRI International St. Jude Medical Stanford Biodesign Innovation Program Stanford Biodesign Network Stanford University School of Medicine Strathspey Crown LLC Synteract Takeda Pharmaceuticals Takeda Research Investment Takeda San Diego Takeda San Francisco Tandem Diabetes Target Discovery Telik Thallo Biosciences The Buck Institute for Age Research The Foundry The J. David Gladstone Institutes The Jackson Laboratory The Salk Institute for Biological Studies The Sam & Rose Stein Institute for Research on Aging The Scripps Research Institute Theravance Thermo Fisher Scientific Thermo Fisher Scientific Clinical Diagnostics Thermo Fisher Scientific Scientific Instruments Thermo Fisher Scientific Western Distribution Center Thermo Fisher Scientific Life Sciences Mass Spectrometry Thermo Fisher Scientific Chino Warehouse Thermo Fisher Scientific Plastic Consumables Thermo Fisher Scientific Process Instruments Division Thermo Fisher Scientific Centrifuges Thermo Fisher Scientific Laboratory Plastics Thermo Fisher Scientific Environmental Monitoring Technologies TriNet Trius Therapeutics UC, Berkeley UC, Davis UC, Irvine UC, Los Angeles UC, Riverside UC, San Diego UC, Santa Barbara UC, Santa Cruz University of California University of Southern California Veridex Vivus Volcano Corporation WaveTec Vision Wave 80 Biosciences Wilson Sonsini Goodrich & Rosati Wind River XOMA (US) LLC Zimmer Dental Zimmer Holdings 18

20 SPONSORSHIP COMMITMENT FORM Sponsorship Information California Biomedical Industry Report Platinum ($10,000) Gold ($5,000) Non-Profit/Academic Research Institution ($3,500) Annual Reception in D.C. Platinum ($7,500) Gold ($3,000) An Evening With Thought Leaders Platinum ($20,000) Gold ($10,000) Silver ($5,000) Company Information Organization Name Address 1 Annual Diagnostics Forum $3,500 CHI Annual Meeting Board Dinner ($25,000) Platinum ($20,000) Gold ($10,000) Silver ($5,000) Coffee/Networking Break ($5,000) Patient/Non-Profit Scholarship ($5,000) End of Session Reception in D.C. $1,500 Coverage, Payment & the Value of Biomedical Innovation NIH Return on Investment Corporate Level ($10,000) Non-Profit/Academic Research Institution Level ($5,000) Presenting Level ($25,000) Supporting Level ($10,000) Website Address 2 Type of Business Contact Name Contact Title City, State Zip Phone Fax Billing Information Same as above (Indicate who should receive sponsorship invoice) Contact Name Address 1 Contact Title Address 2 Phone Fax Card Number City State Payment Method (Please check one) Check Enclosed Visa/MC/Amex Please Invoice Zip Exp. Date Cardholder Name Address 1 Total $ Address 2 Phone City, State Zip Cardholder Signature Please mail, fax, or sponsorship committment form to: Attn: CHI Business Development, California Healthcare Institute, 888 Prospect Street, Suite 220, La Jolla, CA (858) (858) fax Ingraham@chi.org 19